0 (232) 454 14 14

Professor İnanç Karapolat

Professor İnanç Karapolat

Short Biography

Prof. Dr. İnanç Karapolat works in the field of Nuclear Medicine.

From 1990 to 1997, undergraduate studies were completed at Ege Üniversitesi Tıp Fakültesi. From 1999 to 2004, specialty training was undertaken in the Department of Nuclear Medicine at the same faculty.

From 2004 to 2010, worked as a specialist physician at Özel İzmir Şifa Hastanesi.

Education

1990–1997: Ege Üniversitesi Tıp Fakültesi, undergraduate studies.

1999–2004: Ege Üniversitesi Tıp Fakültesi, Department of Nuclear Medicine, medical specialty training in Nuclear Medicine.

Title of Medical Specialty Thesis:

Comparative Evaluation of Tc99m Tetrofosmin Scintimammography in the Investigation of Palpable and Nonpalpable Breast Masses with Mammography, Ultrasonography, and Histopathology Findings

Advisor: Prof. Dr. A. Murat Argon

Professional Experience

2004–2010
Özel İzmir Şifa Hastanesi
Specialist Physician

2010–2014
Şifa Üniversitesi Tıp Fakültesi, Department of Nuclear Medicine
Assistant Professor

2014–2016
Şifa Üniversitesi Tıp Fakültesi, Department of Nuclear Medicine
Associate Professor

2016–2017
Çiğli Bölge Eğitim Hastanesi, Department of Nuclear Medicine
Associate Professor

2018–2020
Özel Kent Hastanesi, Department of Nuclear Medicine
Associate Professor

2020–present
Özel Tınaztepe Galen Hastanesi, Department of Nuclear Medicine
Associate Professor

Academic Studies and Publications

Academic Titles

Assistant Professorship Date: 25.04.2011

Associate Professorship Date: 27.01.2014

Overseas Observership Training Period

  • Cleveland Clinic Department of Molecular and Functional Imaging Observership Program, Cleveland/USA - 2005
  • University of Pittsburgh Department of Nuclear Medicine PET/CT Observership Program, Pittsburgh/USA - 2007

Certificates of Achievement

  • Interuniversity Council Foreign Language Examination (ÜDS) - English Health Sciences - 86.250 – 25.03.2007
  • Turkish Board of Nuclear Medicine - November 2009
  • European Board of Nuclear Medicine - May 2010

Publications

Articles published in international peer-reviewed journals

  1. Cokmert S, Tanriverdi O, Karapolat I, Demir L, Bayoglu V, Can A, Akyol M, Yılmaz Y, Oktay Tarhan M. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study. JBUON. 2016 Nov-Dec;21(6):1410-1418.
  2. Öztürk H, Karapolat I. 18F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer. Oncol Lett. 2016 Jan;11(1):316-322.
  3. Karapolat I, Karapolat HU, Kirazli Y, Capaci K, Akkoc Y, Kumanlioglu K. Longitudinal study of bone loss in chronic spinal cord injury patients. J Phys Ther Sci. 2015 May;27(5):1429-33.
  4. Ozturk H, Karapolat I, Saklamaz A. Bilateral metachronous adrenal metastases of operated renal cell carcinoma. Urologia. 2015 Apr-Jun;82(2):114-7.
  5. Öztürk H, Karapolat I. Efficacy of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy. Exp Ther Med. 2015 Mar;9(3):717-724.
  6. Oncel G, Oncel D, Karapolat I, Sever F. The effectiveness of whole body magnetic resonance imaging (diffusion-weighted imaging and fat saturated T2-weighted imaging) in the evaluation of patients with newly diagnosed malignancies in comparison with positron emission tomography-computed tomography. JBR-BTR. 2014 Nov-Dec;97(6):341-5.
  7. Karapolat I, Sertpoyraz F, Oncel G, Kobak S, Yalcin M, Kumanlioglu K. Demonstrating disease activity in patients with rheumatoid arthritis. Is 18F FDG PET a sensitive method? Nuklearmedizin. 2013 Dec 13;52(6):244-9.
  8. Karapolat I, Kalfa M, Keser G, Yalcin M, Inal V, Kumanlioglu K, Parildar T, Aksu K. Comparison of F18 FDG PET/CT findings with current clinical disease status in patients with Takayasu's arteritis. Clin Exp Rheumatol. 2013, 31, 1, Suppl.75:0015-0021.
  9. Sanal SM, Sivrikoz ON, Karapolat I, Karademir S. Complete clinical response in squamous cell carcinoma of the rectum with liver metastases. J Clin Oncol. 2011 Nov 20;29(33):e806-8.
  10. Turker O, Karapolat I, Doğan I. A semihot-semicold but pure adenoma. Thyroid 2008;18:793.
  11. Turker O, Karapolat I. There is immunological benefit of selenium treatment in autoimmune thyroiditidis. Thyroid 2008;18:671-2.
  12. Yulug B, Bakar M, Karapolat I, Guzel O, Schäbitz WR. A case of idiopathic basal ganglia calcification presenting with only acting-out attacks and mild cognitive impairment: PET findings. J. Neuropsychiatry Clin. Neurosci. 2007;19:348-9.
  13. Yulug B, Bakar M, Karapolat I, Guzel O, Schäbitz WR. Topiramate improves glucose metabolism in choreatic and depressive patient: PET findings. J. Neuropsychiatry Clin. Neurosci. 2007;19:346-7.
  14. Akgun A, Cok G, Karapolat I, Goksel T, Burak Z. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer. Ann. Nucl. Med. 2006;20:269-75.
  15. Turker O, Kumanlioglu K, Karapolat I, Dogan I. Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J. Endocrinol. 2006;190:151-6.

Papers presented at international scientific meetings and published in the proceedings

  1. Fidan Yildiz, Inanc Karapolat, Güray Oncel. Role of quantitative perfusion scintigraphy evaluation in determination of the efficiency of the procedure before lung volume reduction coil (LVRC) treatment for severe emphysema. European Respiratory Society International Congress, London, UK, 2016.
  2. Karapolat Inanc, Sertpoyraz Filiz, Oncel Guray, Kobak Senol, Kumanlioglu Kamil. Is F-18 FDG PET a sensitive method in demonstrating disease activity in patients with rheumathoid arthritis? Second Balkan Congress of Nuclear Medicine, Belgrade, Serbia, 2013.
  3. Yilmaz, E; Akkoclu, A; Gulsen, A; Sever, F; Genc, B; Kalaycioglu, S; Karapolat, I; Onen, A. Comparison of diffusion-weighted magnetic resonance imaging versus F-18 fluorodeoxyglucose positron emission tomography in the assessment of N2 lymph node metastasis due to non-small cell lung cancer. World Conference on Lung Cancer (WCLC), Sydney, Australia, 2013.
  4. Argon, M; Tani, E; Omur, O; Oral, A; Karapolat, I; Yararbas, U. The value of diffuse slow washout rate of Tl-201 in type 2 diabetes mellitus patients with and without perfusion defects in myocardial perfusion scintigraphy. 25th Annual Congress of the European Association of Nuclear Medicine (EANM), Milan, Italy, 2012.
  5. Akgun A, Yuceyar N, Karapolat I, Ozbelen Alper Y, Kocaman A. Is There any Correlation Between Fatigue in Multipl Sclerosis and Cerebral Blood Flow as Detected by Tc-99m HMPAO SPECT? Annual Congress of the EANM, Istanbul, Turkey, 2005.

B. Presentations

  • B6. Akgun A, Cok G, Karapolat I, Goksel T, Burak Z. Tc-99m MIBI SPECT as an indicator of prognosis for patients with small cell lung cancer. Annual Congress of the EANM, Istanbul, Turkey, 2005.
  • B7. Hacibeyoglu I, Ozyurt O, Asıkoğlu M, Karapolat I, Tunc M. Biodistribution of F-18 FDG (fluoro-2-deoxyglucose) in rabbits. International Congress of Radiopharmacy and Radiopharmaceutical Chemistry, Istanbul, Turkey, 2004.
  • B8. Özcan Z, Karapolat I, Dirlik A, Ömür Ö, Kumanlıoğlu K, Özkılıç H. Papillary Thyroid Carcinoma in Childhood and Adolescence. Annual Congress of the EANM, Amsterdam, Holland, 2003.
  • B9. Yararbaş U, Erinç R, Karapolat I, Kumanlıoğlu K. Comparison of Pinhole/High Resolution Parallel Hole and Early/Late Tc99m-MIBI Images in Parathyroid Imaging. Congress of the European Association of Nuclear Medicine, Napoli, Italy, 2001.
  • B10. Dirlik A, Erinç R, Burak Z, Karapolat I, Tavus S, Bacakoglu F. Assessment of alveolar epithelial permeability in diabetics using 99mTc DTPA aerosol scintigraphy. Congress of the European Association of Nuclear Medicine, Paris, France, 2000.

C. Articles published in national peer-reviewed journals

  • C1.İnanç Karapolat. Akciğer Kanserinde Tedavi Yanıtını Değerlendirmede FDG PET/BT Görüntüleme. Nucl Med Semin 2018;4:43-51.
  • C2. Hatipoğlu F, Karapolat I, Ömür Ö, Akgün A, Yanarateş A, Kumanlıoğlu K. Recurrence Incidence in Differentiated Thyroid Cancers and the Importance of Diagnostic Iodine-131 Scintigraphy in Clinical Follow-up. Mol Imaging Radionucl Ther 2016 Jun 5;25(2):85-90.
  • C3. Mine Genc, Berhan Genc, Serap Karaarslan, Secil Kurtulmus, Seyhan Yalaz, İnanç Karapolat. Concurrent Endometrial Carcinosarcoma and Thyroid Papillary Carcinoma: PET CT Imaging Findings. Mol Imaging Radionucl Ther 2015;24:34-37.
  • C4.Karapolat I, Kumanlıoğlu K. Enfeksiyöz ve Enflamatuar Hastalıkların Pozitron Emisyon Tomografi/Bilgisayarlı Tomografi ile Görüntülenmesi. Düzce Üniversitesi Tıp Fakültesi Dergisi. 2014;16(2):63-69.
  • C5.Karapolat I, Oncel G, Kumanlıoğlu K. Clinically Occult Pituitary Adenoma Can Appear as a Hypermetabolic Lesion on Whole Body FDG PET Imaging in a Patient with Lymphoma. Mol Imaging Radionucl Ther. 2013 Apr;22(1):18-20.
  • C6.Karapolat I, Kumanlıoğlu K. Impact of FDG-PET/CT for the Detection of Unknown Primary Tumours in Patients with Cervical Lymph Node Metastases. Mol Imaging Radionucl Ther. 2012 Aug;21(2):63-8.
  • C7. Cok G, Karapolat I, Turhan K, Göksel T, Cakan A, Nart D, Kumanlıoğlu K. Akciğer Kanserlerinin Tanı ve Evrelemesinde Pozitron Emisyon Tomografisinin Tanısal Değeri. Solunum 2006;8(2):55-59.
  • C8. Yıldız F, Özyurt Ö, Karapolat I, Oncel G, Kumanlıoğlu K, Oncel D. Erken Evre Akciğer Kanseri Olgularımızın Klinik ve Görüntüleme Bulguları (Radyoloji ve PET). Turk. J. Nuc. Med. 2007;16.
  • C9. Kömürcülü N, İnce A, Bakar E, Yılmaz H, Karapolat I, Selçuki D. Huntington Hastalığı: İki Olgu. Ege Tıp Dergisi 2006;45(2):139-143.
  • C10. Özgür Ö, Özcan Z, Akgün A, Karapolat İ, Özkılıç H. Papillary microcarcinoma of the thyroid gland presenting initially with regional or distant metastasis. Turk. J. Nucl. Med. 2005;14(4).
  • C11. Özgür Ö, Karapolat İ. Kalsifikasyon odağı saptanmayan metastatik karaciğer lezyonunda Tc99m MDP tutulumu. Turk. J. Nucl. Med. 2002;11(4).

D. Papers presented at national scientific meetings and published in the proceedings

  • D1. Fidan Sever, Aşkın Gülşen, Ayşe Pelin Girgin, Filiz Hatipoğlu, İnanç Karapolat, Güray Öncel. Bronkoskopik Volüm Azaltıcı Sarmal tedavisi (LVRC) öncesi V/Q Sintigrafi değerlendirmesinin işlemin etkinliğini belirlemedeki rolü. TÜSAD 37. Ulusal Kongresi, İzmir, Türkiye, Ekim 2015.
  • D2.Karapolat I, Sertpoyraz F, Öncel G, Kobak Ş, Kumanlıoğlu K. F-18 FDG PET-BT Romatoid Artrit Hastalarında Hastalık Aktivitesini Göstermede Duyarlı Bir Yöntem midir? 25. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 2013.
  • D3. Çerçi U, Bozdemir E, Karapolat I. Servikal Lenf Bezi Metastazı olan Hastalarda Primer Odak Araştırılmasında FDG PET/BT'nin Etkinliği. 34. Türk Ulusal Kulak Burun Boğaz ve Baş Boyun Cerrahisi Kongresi, Antalya, Türkiye, Ekim 2012.
  • D4. Yalçın M, Karadeniz M, Genç B, Öncel G, Karapolat I, Sever F. Mediastende Ektopik Paratiroid Adenomu ve Ciddi Vitamin D3 Eksikliği Olan Olgu. İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri, İstanbul, Türkiye, Mart 2012.
  • D5. Yalçın M, Sivrikoz O, Karaarslan S, Karapolat I, Sanal S. Meme ve Paratiroid Kanseri Birlikteliği Olan Bir Olgu. İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri, İstanbul, Türkiye, Mart 2012.
  • D6. Yalçın M, Karadeniz M, Sanal S, Demir Ö, Karapolat I, Gökduman A, Buğdaycı H, Arıcan A, Kırcı A. Pankreas Başında Yerleşmiş Tıkanma Sarılığı ve Kan Şekeri Yükselmesiyle Teşhis Edilen Granülositik Sarkom Olgusu. İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri, İstanbul, Türkiye, Mart 2012.
  • D7. Argon M, Yararbaş U, Karapolat I. PET-BT’de Hatalı Pozitiflik Nedenlerinden Biri: Sarkoidoz. 23. Ulusal Nükleer Tıp Kongresi, İzmir, Türkiye, 2011.
  • D8. Sivrikoz N.O, Karaarslan S, Karapolat I. Primer Tiroid Angiosarkomu: Olgu Sunumu. 21. Ulusal Patoloji Kongresi, İzmir, Türkiye, 2011.
  • D9.Karapolat I, Özyurt Ö, Kumanlıoğlu K, Kuşçu B. Yaygın akciğer tüberkülozlu bir olguda PET/BT bulguları. 21. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 2009.
  • D10.Karapolat I, Özyurt Ö, Kumanlıoğlu K, Uyar M. Orbital lenfomalı bir olguda PET/BT ile evreleme ve tedaviye yanıtın değerlendirilmesi. 21. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 2009.

Academic Titles

  • Assistant Professor Date: 25.04.2011
  • Associate Professorship Date: 27.01.2014

Training Period as an Overseas Observer

  1. Cleveland Clinic Department of Molecular and Functional Imaging Observership Program, Cleveland/USA – 2005
  2. University of Pittsburgh Department of Nuclear Medicine PET/CT Observership Program, Pittsburgh/USA – 2007

Certificates of Achievement

  1. Interuniversity Board Foreign Language Exam (ÜDS) – English Health Sciences – 86.250 – 25.03.2007
  2. Turkish Board of Nuclear Medicine – November 2009
  3. European Board of Nuclear Medicine – May 2010

Publications

Articles published in international peer-reviewed journals

  1. A1. Cokmert S, Tanriverdi O, Karapolat I, Demir L, Bayoglu V, Can A, Akyol M, Yılmaz Y, Oktay Tarhan M. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study. JBUON. 2016 Nov-Dec;21(6):1410-1418.
  2. A2. Öztürk H, Karapolat I. 18F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer. Oncol Lett. 2016 Jan;11(1):316-322.
  3. A3.Karapolat I, Karapolat HU, Kirazli Y, Capaci K, Akkoc Y, Kumanlioglu K. Longitudinal study of bone loss in chronic spinal cord injury patients. J Phys Ther Sci. 2015 May;27(5):1429-33.
  4. A4. Ozturk H, Karapolat I, Saklamaz A. Bilateral metachronous adrenal metastases of operated renal cell carcinoma. Urologia. 2015 Apr-Jun;82(2):114-7.
  5. A5. Öztürk H, Karapolat I. Efficacy of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy. Exp Ther Med. 2015 Mar;9(3):717-724.
  6. A6. Oncel G, Oncel D, Karapolat I, Sever F. The effectiveness of whole body magnetic resonance imaging (diffusion-weighted imaging and fat saturated T2-weighted imaging) in the evaluation of patients with newly diagnosed malignancies in comparison with positron emission tomography-computed tomography. JBR-BTR. 2014 Nov-Dec;97(6):341-5.
  7. A7.Karapolat I, Sertpoyraz F, Oncel G, Kobak S, Yalcin M, Kumanlioglu K. Demonstrating disease activity in patients with rheumatoid arthritis. Is 18F FDG PET a sensitive method? Nuklearmedizin. 2013 Dec 13;52(6):244-9.
  8. A8.Karapolat I, Kalfa M, Keser G, Yalcin M, Inal V, Kumanlioglu K, Parildar T, Aksu K. Comparison of F18 FDG PET/CT findings with current clinical disease status in patients with Takayasu's arteritis. Clin Exp Rheumatol. 2013, 31, 1, Suppl.75:0015-0021.
  9. A9. Sanal SM, Sivrikoz ON, Karapolat I, Karademir S. Complete clinical response in squamous cell carcinoma of the rectum with liver metastases. J Clin Oncol. 2011 Nov 20;29(33):e806-8.
  10. A10. Turker O, Karapolat I, Dogan I. A semihot-semicold but pure adenoma. Thyroid 2008;18:793.
  11. A11. Turker O, Karapolat I. There is immunological benefit of selenium treatment in autoimmune thyroiditidis. Thyroid 2008;18:671-2.
  12. A12. Yulug B, Bakar M, Karapolat I, Guzel O, Schäubitz WR. A case of idiopathic basal ganglia calcification presenting with only acting-out attacks and mild cognitive impairment: PET findings. J. Neuropsychiatry Clin. Neurosci. 2007;19:348-9.
  13. A13. Yulug B, Bakar M, Karapolat I, Guzel O, Schäubitz WR. Topiramate improves glucose metabolism in choreatic and depressive patient: PET findings. J. Neuropsychiatry Clin. Neurosci. 2007;19:346-7.
  14. A14. Akgun A, Cok G, Karapolat I, Goksel T, Burak Z. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer. Ann. Nucl. Med. 2006;20:269-75.
  15. A15. Turker O, Kumanlioglu K, Karapolat I, Dogan I. Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J. Endocrinol. 2006;190:151-6.

B. Papers presented at international scientific meetings and published in the proceedings book

  1. B1. Fidan Yildiz, Inanc Karapolat, Güray Oncel. Role of quantitative perfusion scintigraphy evaluation in determination of the efficiency of the procedure before lung volume reduction coil (LVRC) treatment for severe emphysema. European Respiratory Society International Congress, London, UK, 2016.
  2. B2.Karapolat Inanc, Sertpoyraz Filiz, Oncel Guray, Kobak Senol, Kumanlioglu Kamil. Is F-18 FDG PET a sensitive method in demonstrating disease activity in patients with rheumathoid arthritis? Second Balkan Congress of Nuclear Medicine, Belgrade, Serbia, 2013.

Conference presentations

  1. D11. Özyurt Ö, Karapolat I, Kumanlıoğlu K, Hacıbeyoğlu I, Tunç M. PET çalışmasında Geç Görüntünün Önemi; Serviks Karsinomu Tanılı Olgunun Tedavi Sonrası Değerlendirilmesi. Nükleer Tıp Sempozyumu Pozitron Emisyon Tomografi konferansı, Ankara, Türkiye, Mart 2005.
  2. D12. Özyurt Ö, Karapolat I, Kumanlıoğlu K, Hacıbeyoğlu I, Tunç M. Metastaz Taraması Nedeniyle PET Tetkiki Yapılan ve Tesadüfen Primer Tiroid Malignitesi Saptanan Olgu. Nükleer Tıp Sempozyumu Pozitron Emisyon Tomografisi konferansı, Ankara, Türkiye, Mart 2005.
  3. D13. Dirlik A, Çok G, Karapolat I, Göksel T, Burak Z. Küçük hücreli akciğer kanserinde kemoterapi yanıtını önceden belirlemede Tc99m MIBI SPECT. 16. Ulusal Nükleer Tıp Kongresi, Samsun, Türkiye, 2003.
  4. D14.Karapolat I, Özcan Z, Dirlik A, Ömür Ö, Kumanlıoğlu K, Özkılıç H. Çocukluk çağında papiller tiroid kanserleri. 16. Ulusal Nükleer Tıp Kongresi, Samsun, Türkiye, 2003.
  5. D15. Dirlik A, Karapolat I, Göksel T, Özcan Z, Burak Z. Comparison of Tc-99m MIBI uptake ratios in lung cancer using two different regions of interests. 15. Ulusal Nükleer Tıp Kongresi, Kuşadası, Türkiye, 2002.

B3. Yilmaz, E; Akkoclu, A; Gulsen, A; Sever, F; Genc, B; Kalaycioglu, S; Karapolat, I; Onen, A. Comparison of diffusion-weighted magnetic resonance imaging versus F-18 fluorodeoxyglucose positron emission tomography in the assessment of N2 lymph node metastasis due to non-small cell lung cancer. World Conference on Lung Cancer (WCLC), Sydney, Australia, 2013.

B4. Argon, M; Tani, E; Omur, O; Oral, A; Karapolat, I; Yararbas, U. The value of diffuse slow washout rate of Tl-201 in type 2 diabetes mellitus patients with and without perfusion defects in myocardial perfusion scintigraphy. 25th Annual Congress of the European Association of Nuclear Medicine (EANM), Milan, Italy, 2012.

B5. Akgun A, Yuceyar N, Karapolat I, Ozbelen Alper Y, Kocaman A. Is There any Correlation Between Fatigue in Multiple Sclerosis and Cerebral Blood Flow as Detected by Tc-99m HMPAO SPECT? Annual Congress of the EANM, Istanbul, Turkey, 2005.

B6. Akgun A, Cok G, Karapolat I, Goksel T, Burak Z. Tc-99m MIBI SPECT as an indicator of prognosis for patients with small cell lung cancer. Annual Congress of the EANM, Istanbul, Turkey, 2005.

B7. Hacibeyoglu I, Ozyurt O, Ası koglu M, Karapolat I, Tunc M. Biodistribution of F-18 FDG (fluoro-2-deoxyglucose) in rabbits. International Congress of Radiopharmacy and Radiopharmaceutical Chemistry, Istanbul, Turkey, 2004.

B8. Özcan Z, Karapolat I, Dirlik A, Ömür Ö, Kumanlıoğlu K, Özkılıç H. Papillary Thyroid Carcinoma in Childhood and Adolescence. Annual Congress of the EANM, Amsterdam, Holland, 2003.

B9. Yararbaş U, Erinç R, Karapolat I, Kumanlıoğlu K. Comparison of Pinhole/High Resolution Parallel Hole and Early/Late Tc99m-MIBI Images in Parathyroid Imaging. Congress of the European Association of Nuclear Medicine, Napoli, Italy, 2001.

B10. Dirlik A, Erinç R, Burak Z, Karapolat I, Tavus S, Bacakoglu F. Assessment of alveolar epithelial permeability in diabetics using 99mTc DTPA aerosol scintigraphy. Congress of the European Association of Nuclear Medicine, Paris, France, 2000.

C. Articles published in national peer-reviewed journals:

C1.İnanç Karapolat. Akciğer Kanserinde Tedavi Yanıtını Değerlendirmede FDG PET/BT Görüntüleme. Nucl Med Semin 2018;4:43-51.

C2. Hatipoğlu F, Karapolat I, Ömür Ö, Akgün A, Yanarateş A, Kumanlıoğlu K. Recurrence Incidence in Differentiated Thyroid Cancers and the Importance of Diagnostic Iodine-131 Scintigraphy in Clinical Follow-up. Mol Imaging Radionucl Ther 2016 Jun 5;25(2):85-90.

C3. Mine Genc, Berhan Genc, Serap Karaarslan, Secil Kurtulmus, Seyhan Yalaz, İnanç Karapolat. Concurrent Endometrial Carcinosarcoma and Thyroid Papillary Carcinoma: PET CT Imaging Findings. Mol Imaging Radionucl Ther 2015;24:34-37.

C4.Karapolat I, Kumanlıoğlu K. Enfeksiyöz ve Enflamatuar Hastalıkların Pozitron Emisyon Tomografi/Bilgisayarlı Tomografi ile Görüntülenmesi. Düzce Üniversitesi Tıp Fakültesi Dergisi. 2014;16(2):63-69.

C5.Karapolat I, Oncel G, Kumanlıoğlu K. Clinically Occult Pituitary Adenoma Can Appear as a Hypermetabolic Lesion on Whole Body FDG PET Imaging in a Patient with Lymphoma. Mol Imaging Radionucl Ther. 2013 Apr;22(1):18-20.

C6.Karapolat I, Kumanlıoğlu K. Impact of FDG-PET/CT for the Detection of Unknown Primary Tumours in Patients with Cervical Lymph Node Metastases. Mol Imaging Radionucl Ther. 2012 Aug;21(2):63-8.

C7. Cok G, Karapolat I, Turhan K, Göksel T, Cakan A, Nart D, Kumanlıoğlu K. Akciğer Kanserlerinin Tanı ve Evrelemesinde Pozitron Emisyon Tomografisinin Tanısal Değeri. Solunum 2006;8(2):55-59.

C8. Yıldız F, Özyurt Ö, Karapolat I, Oncel G, Kumanlıoğlu K, Oncel D. Erken Evre Akciğer Kanseri Olgularımızın Klinik ve Görüntüleme Bulguları (Radyoloji ve PET). Turk. J. Nuc. Med. 2007;16.

C9. Kömürcülü N, İnce A, Bakar E, Yılmaz H, Karapolat I, Selçuki D. Huntington Hastalığı: İki Olgu. Ege Tıp Dergisi 45(2):139-143, 2006.

C10. Özgür Ö, Özcan Z, Akgün A, Karapolat İ, Özkılıç H. Papillary microcarcinoma of the thyroid gland presenting initially with regional or distant metastasis. Turk. J. Nucl. Med. 2005;14(4).

C11. Özgür Ö, Karapolat İ. Kalsifikasyon odağı saptanmayan metastatik karaciğer lezyonunda Tc99m MDP tutulumu. Turk. J. Nucl. Med. 2002;11(4).

D. Papers presented at national scientific meetings and published in the proceedings book:

D1. Fidan Sever, Aşkın Gülşen, Ayşe Pelin Girgin, Filiz Hatipoğlu, İnanç Karapolat, Güray Öncel. Bronkoskopik Volüm Azaltıcı Sarmal tedavisi (LVRC) öncesi V/Q Sintigrafi değerlendirmesinin işlemin etkinliğini belirlemedeki rolü. TÜSAD 37. Ulusal Kongresi. İzmir, Türkiye, Ekim 2015.

D2.Karapolat I, Sertpoyraz F, Öncel G, Kobak Ş, Kumanlıoğlu K. F-18 FDG PET-BT Romatoid Artrit Hastalarında Hastalık Aktivitesini Göstermede Duyarlı Bir Yöntem midir? 25. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 2013.

D3. Çerçi U, Bozdemir E, Karapolat I. Servikal Lenf Bezi Metastazı olan Hastalarda Primer Odak Araştırılmasında FDG PET/BT'nin Etkinliği, 34. Türk Ulusal Kulak Burun Boğaz ve Baş Boyun Cerrahisi Kongresi, Antalya, Türkiye, Ekim 2012.

D4. Yalçın M, Karadeniz M, Genç B, Öncel G, Karapolat I, Sever F. Mediastende Ektopik Paratiroid Adenomu ve Ciddi Vitamin D3 Eksikliği Olan Olgu. İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri, İstanbul, Türkiye, Mart 2012.

D5. Yalçın M, Sivrikoz O, Karaarslan S, Karapolat I, Sanal S. Meme ve Paratiroid Kanseri Birlikteliği Olan Bir Olgu. İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri, İstanbul, Türkiye, Mart 2012.

  1. D6. Yalçın M, Karadeniz M, Sanal S, Demir Ö, Karapolat I, Gökduman A, Buğdaycı H, Arıcan A, Kırcı A. Pankreas Başında Yerleşmiş Tıkanma Sarılığı ve Kan Şekeri Yükselmesiyle Teşhis Edilen Granülositik Sarkom Olgusu. İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri, İstanbul, Türkiye, Mart 2012.
  2. D7. Argon M, Yararbaş U, Karapolat I. PET-BT’de Hatalı Pozitiflik Nedenlerinden Biri: Sarkoidoz. 23. Ulusal Nükleer Tıp Kongresi, İzmir, Türkiye, 2011.
  3. D8. Sivrikoz N.O, Karaarslan S, Karapolat I. Primer Tiroid Angiosarkomu: Olgu Sunumu. 21. Ulusal Patoloji Kongresi, İzmir, Türkiye, 2011.
  4. D9.Karapolat I, Özyurt Ö, Kumanlıoğlu K, Kuşçu B. Yaygın akciğer tüberkülozlu bir olguda PET/BT bulguları. 21. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 2009.
  5. D10.Karapolat I, Özyurt Ö, Kumanlıoğlu K, Uyar M. Orbital lenfomalı bir olguda PET/BT ile evreleme ve tedaviye yanıtın değerlendirilmesi. 21. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 2009.
  6. D11. Özyurt Ö, Karapolat I, Kumanlıoğlu K, Hacıbeyoğlu I, Tunç M. PET çalışmasında geç görüntünün önemi; serviks karsinomu tanılı olgunun tedavi sonrası değerlendirilmesi. Nükleer Tıp Sempozyumu Pozitron Emisyon Tomografi Konferansı, Ankara, Türkiye, Mart 2005.
  7. D12. Özyurt Ö, Karapolat I, Kumanlıoğlu K, Hacıbeyoğlu I, Tunç M. Metastaz taraması nedeniyle PET tetkiki yapılan ve tesadüfen primer tiroid malignitesi saptanan olgu. Nükleer Tıp Sempozyumu Pozitron Emisyon Tomografisi Konferansı, Ankara, Türkiye, Mart 2005.
  8. D13. Dirlik A, Çok G, Karapolat I, Göksel T, Burak Z. Küçük hücreli akciğer kanserinde kemoterapi yanıtını önceden belirlemede Tc99m MIBI SPECT. 16. Ulusal Nükleer Tıp Kongresi, Samsun, Türkiye, 2003.
  9. D14.Karapolat I, Özcan Z, Dirlik A, Ömür Ö, Kumanlıoğlu K, Özkılıç H. Çocukluk çağında papiller tiroid kanserleri. 16. Ulusal Nükleer Tıp Kongresi, Samsun, Türkiye, 2003.
  10. D15. Dirlik A, Karapolat I, Göksel T, Özcan Z, Burak Z. Comparison of Tc-99m MIBI uptake ratios in lung cancer using two different regions of interests. 15. Ulusal Nükleer Tıp Kongresi, Kuşadası, Türkiye, 2002.
  • Evaluation of response to gemcitabine plus cisplatin-based chemotherapy using positron emission computed tomography for metastatic bladder cancer
    Authors: Öztürk, H (Ozturk, Hakan) [1], [3]; Karapolat, I (Karapolat, Inanc) [2]
    Journal: WORLD JOURNAL OF CLINICAL CASES
    Volume: 11
    Issue: 36
    Publication date: DEC 26 2023
    DOI: 10.12998/wjcc.v11.i36.8447
  • Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses
    Authors: Turker, O (Turker, Omer); Kumanlioglu, K (Kumanlioglu, Kamil); Karapolat, I (Karapolat, Inanc); Dogan, I (Dogan, Ismail)
    Journal: JOURNAL OF ENDOCRINOLOGY
    Volume: 190
    Issue: 1
    Pages: 151-156
    Publication date: JUL 2006
    DOI: 10.1677/joe.1.06661
  • Efficacy of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy
    Authors: Öztürk, H (Ozturk, Hakan) [1]; Karapolat, I (Karapolat, Inanc) [2]
    Journal: EXPERIMENTAL AND THERAPEUTIC MEDICINE
    Volume: 9
    Issue: 3
    Pages: 717-724
    Publication date: MAR 2015
    DOI: 10.3892/etm.2015.2187
  • F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer
    Authors: Öztürk, H (Ozturk, Hakan) [1]; Karapolat, I (Karapolat, Inanc) [2]
    Journal: ONCOLOGY LETTERS
    Volume: 11
    Issue: 1
    Pages: 316-322
    Publication date: JAN 2016
    DOI: 10.3892/ol.2015.3903
  • Longitudinal study of bone loss in chronic spinal cord injury patients
    Authors: Karapolat, I (Karapolat, Inanc) [1]; Karapolat, HU (Karapolat, Hale Uzumcugil) [2]; Kirazli, Y (Kirazli, Yesim) [2]; Capaci, K (Capaci, Kazim) [2]; Akkoc, Y (Akkoc, Yesim) [2]; Kumanlioglu, K (Kumanlioglu, Kamil) [3]
    Journal: JOURNAL OF PHYSICAL THERAPY SCIENCE
    Volume: 27
    Issue: 5
    Pages: 1429-1433
    Publication date: MAY 2015
    DOI: 10.1589/jpts.27.1429
  • The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study
    Authors: Cokmert, S (Cokmert, Suna) [1]; Tanriverdi, O (Tanriverdi, Ozgur) [2]; Karapolat, I (Karapolat, Inanc) [3]; Demir, L (Demir, Lutfiye) [1]; Bayoglu, V (Bayoglu, Vedat) [1]; Can, A (Can, Alper) [1]; Akyol, M (Akyol, Murat) [1]; Yilmaz, Y (Yilmaz, Yasar) [1]; Tarhan, MO (Tarhan, Mustafa Oktay) [1]
    Journal: JOURNAL OF BUON
    Volume: 21
    Issue: 6
    Pages: 1410-1418
    Publication date: NOV-DEC 2016
  • Impact of FDG-PET/CT for the Detection of Unknown Primary Tumours in Patients with Cervical Lymph Node Metastases
    Authors: Karapolat, I (Karapolat, Inanc) [1]; Kumanlioglu, K (Kumanlioglu, Kamil) [2]
    Journal: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
    Volume: 21
    Issue: 2
    Pages: 63-68
    Publication date: AUG 2012
    DOI: 10.4274/Mirt.344
  • Recurrence Incidence in Differentiated Thyroid Cancers and the Importance of Diagnostic Iodine-131 Scintigraphy in Clinical Follow-up
    Authors: Hatipoglu, F (Hatipoglu, Filiz) [1]; Karapolat, I (Karapolat, Inanc) [1]; Ömür, Ö (Omur, Ozgur) [2]; Akgün, A (Akgun, Aysegul) [2]; Yanarates, A (Yanarates, Ahmet) [3]; Kumanlioglu, K (Kumanlioglu, Kamil) [2]
    Journal: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
    Volume: 25
    Issue: 2
    Pages: 85-90
    Publication date: JUN 2016
    DOI: 10.4274/mirt.35220
  • Concurrent Endometrial Carcinosarcoma and Thyroid Papillary Carcinoma: PET CT Imaging Findings
    Authors: Genc, M (Genc, Mine) [1]; Genc, B (Genc, Berhan) [2]; Karaarslan, S (Karaarslan, Serap) [3]; Kurtulmus, S (Kurtulmus, Secil) [4]; Yalaz, S (Yalaz, Seyhan) [5]; Karapolat, I (Karapolat, Inanc) [6]
    Journal: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
    Volume: 24
    Pages: 34-37
    Publication date: JUN 2015
    DOI: 10.4274/mirt.96268
  • Bilateral metachronous adrenal metastases of operated renal cell carcinoma
    Authors: Ozturk, H (Ozturk, Hakan) [1]; Karapolat, I (Karapolat, Inanc) [2]; Saklamaz, A (Saklamaz, Ali) [3]
    Journal: UROLOGIA JOURNAL
    Volume: 82
    Issue: 2
    Pages: 114-117
    Publication date: APR-JUN 2015
    DOI: 10.5301/uro.5000094
  • Clinically Occult Pituitary Adenoma Can Appear as a Hypermetabolic Lesion on Whole Body FDG PET Imaging in a Patient with Lymphoma
    Authors: Karapolat, I (Karapolat, Inanc) [1]; Öncel, G (Oncel, Guray) [2]; Kumanlioglu, K (Kumanlioglu, Kamil) [3]
    Journal: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
    Volume: 22
    Issue: 1
    Pages: 18-20
    Publication date: APR 2013
    DOI: 10.4274/Mirt.258
  • Diagnostic Value of Positron Emission Tomography in Stagins of lung cancers
    Authors: Çok, G (Cok, Gursel) [1]; Karapolat, I (Karapolat, Inanc) [2]; Turhan, K (Turhan, Kutsal) [3]; Göksel, T (Goksel, Tuncay) [1]; Çakan, A (Cakan, Alpaslan); Nart, D (Nart, Deniz) [4]; Kumanlioglu, K (Kumanlioglu, Kamil) [5]
    Journal: EURASIAN JOURNAL OF PULMONOLOGY
    Volume: 8
    Issue: 2
    Pages: 55-59
    Publication date: APR 2006

Professional Memberships

Memberships in Scientific and Professional Organizations:

  1. İzmir Medical Chamber of the Turkish Medical Association
  2. Turkish Society of Nuclear Medicine
  3. European Association of Nuclear Medicine